Qungen Xiao

614 total citations
23 papers, 375 citations indexed

About

Qungen Xiao is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Qungen Xiao has authored 23 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Neurology. Recurrent topics in Qungen Xiao's work include Glioma Diagnosis and Treatment (10 papers), Glycosylation and Glycoproteins Research (6 papers) and Neuroblastoma Research and Treatments (6 papers). Qungen Xiao is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Glycosylation and Glycoproteins Research (6 papers) and Neuroblastoma Research and Treatments (6 papers). Qungen Xiao collaborates with scholars based in China, Germany and United States. Qungen Xiao's co-authors include Baofeng Wang, Ting Lei, Dongsheng Guo, Feng Mao, Kai Shu, Ruifan Xie, Suojun Zhang, Xudong Wu, Xingjiang Yu and Feng Wan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Geriatrics Society.

In The Last Decade

Qungen Xiao

23 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qungen Xiao China 13 193 93 89 81 58 23 375
Devorah Gur‐Wahnon Israel 12 186 1.0× 71 0.8× 61 0.7× 141 1.7× 41 0.7× 16 396
Romain Guiho France 11 192 1.0× 71 0.8× 52 0.6× 58 0.7× 52 0.9× 16 380
Jared S. Rosenblum United States 11 151 0.8× 30 0.3× 44 0.5× 118 1.5× 85 1.5× 38 416
Ihsan Chrifi Netherlands 15 285 1.5× 168 1.8× 40 0.4× 103 1.3× 83 1.4× 21 570
Shao Jian Lin China 12 214 1.1× 44 0.5× 71 0.8× 151 1.9× 44 0.8× 14 447
Lihong Hou China 11 317 1.6× 80 0.9× 60 0.7× 112 1.4× 96 1.7× 29 538
Cláudia C. Faria Portugal 13 206 1.1× 18 0.2× 175 2.0× 81 1.0× 60 1.0× 42 429
Valeriana Cesarini Italy 15 493 2.6× 59 0.6× 55 0.6× 166 2.0× 115 2.0× 25 706
Madoka Inukai Japan 11 96 0.5× 33 0.4× 89 1.0× 54 0.7× 57 1.0× 38 352
Xinke Xu China 12 280 1.5× 37 0.4× 58 0.7× 227 2.8× 58 1.0× 23 430

Countries citing papers authored by Qungen Xiao

Since Specialization
Citations

This map shows the geographic impact of Qungen Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qungen Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qungen Xiao more than expected).

Fields of papers citing papers by Qungen Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qungen Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qungen Xiao. The network helps show where Qungen Xiao may publish in the future.

Co-authorship network of co-authors of Qungen Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Qungen Xiao. A scholar is included among the top collaborators of Qungen Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qungen Xiao. Qungen Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaolin, Peng Peng, Zirong Chen, et al.. (2024). Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages. Cancer Letters. 590. 216801–216801. 11 indexed citations
2.
Lu, Lisen, Qungen Xiao, Yanchao Liu, et al.. (2024). Bioengineer mesenchymal stem cell for treatment of glioma by IL‐12 mediated microenvironment reprogramming and nCD47‐SLAMF7 mediated phagocytosis regulation of macrophages. SHILAP Revista de lepidopterología. 4(6). 20240027–20240027. 15 indexed citations
3.
Liu, Guohao, Po Zhang, Sui Chen, et al.. (2023). FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells. Neuro-Oncology. 25(10). 1788–1801. 11 indexed citations
4.
Chen, Yusi, Junwen Wang, Kuan Huang, et al.. (2022). Clinical Features of Craniopharyngioma With Tumoral Hemorrhage: A Retrospective Case-Controlled Study. Frontiers in Surgery. 9. 845273–845273. 5 indexed citations
5.
Ye, Cuifang, Huan Li, Yachao Li, et al.. (2022). Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE. iScience. 25(9). 104872–104872. 27 indexed citations
6.
Xiao, Qungen, et al.. (2021). Meningeal melanocytoma in the cerebellopontine angle: A rare case report and review of the literature. Oncology and Translational Medicine. 7(1). 35–40. 1 indexed citations
7.
Zhang, Suojun, Qungen Xiao, Junwen Wang, et al.. (2020). Prognostic significance of ARL9 and its methylation in low-grade glioma. Genomics. 112(6). 4808–4816. 34 indexed citations
8.
Xiao, Qungen, et al.. (2020). Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis. Frontiers in Immunology. 11. 593219–593219. 41 indexed citations
9.
Xiao, Qungen, Fangling Cheng, Po Zhang, et al.. (2020). Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling. Cancer Gene Therapy. 27(12). 878–897. 8 indexed citations
10.
Cheng, Fangling, Po Zhang, Qungen Xiao, et al.. (2019). The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma. Frontiers in Oncology. 9. 447–447. 8 indexed citations
11.
Chen, Hao, et al.. (2017). Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway. Oncology Letters. 14(4). 4021–4028. 12 indexed citations
12.
Mao, Feng, Baofeng Wang, Qungen Xiao, et al.. (2017). LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications. Journal of the Neurological Sciences. 383. 56–60. 13 indexed citations
13.
Guo, Dongsheng, Hongkuan Yang, Yang Guo, et al.. (2015). LRIG3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor. Journal of the Neurological Sciences. 350(1-2). 61–68. 13 indexed citations
14.
Liu, Shengwen, Xueyan Wan, Sheng Wang, et al.. (2015). Posttraumatic cerebral infarction in severe traumatic brain injury: characteristics, risk factors and potential mechanisms. Acta Neurochirurgica. 157(10). 1697–1704. 19 indexed citations
15.
Zhang, Yan, et al.. (2014). Hedyotis diffusa Willd extract inhibits the growth of human glioblastoma cells by inducing mitochondrial apoptosis via AKT/ERK pathways. Journal of Ethnopharmacology. 158. 404–411. 21 indexed citations
17.
Zhu, Mingxin, Kai Shu, Heping Wang, et al.. (2013). Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease. Journal of Neuroscience Research. 91(12). 1563–1571. 4 indexed citations
18.
Mao, Feng, Baofeng Wang, Qungen Xiao, et al.. (2013). A role for LRIG1 in the regulation of malignant glioma aggressiveness. International Journal of Oncology. 42(3). 1081–1087. 21 indexed citations
19.
Xie, Ruifan, Hai Yang, Qungen Xiao, et al.. (2012). Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation. Oncology Reports. 29(1). 177–184. 33 indexed citations
20.
Shu, Kai, Qungen Xiao, Fabian Büchele, et al.. (2012). Diagnosis and treatment of clear cell hidradenocarcinoma of the scalp. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(6). 931–936. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026